de Almeida Junior, Joubert, Saul Girelli Neto, Cris Daiane Nobre Sampaio Chagas, Maria Julia Oliveira Caldeira Horing, Renato Vieira Donzelli, Murilo Alves Coelho Neto, Júlia Emanuelli Seganfredo, Janaína Aparecida Medeiros Manca, Dionísio José Paludo Petek, and Willian José Bordin da Silva. “Medication Change, from Natalizumab to Ocrelizumab, in a Patient With Relapsing-Remitting Multiple Sclerosis: Case Report”. Brazilian Journal of Implantology and Health Sciences 6, no. 10 (October 6, 2024): 574–584. Accessed October 16, 2024. https://bjihs.emnuvens.com.br/bjihs/article/view/3764.